More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$149.24B
EPS
8.25
P/E ratio
48.6
Price to sales
13.57
Dividend yield
--
Beta
1.452535
Previous close
$437.75
Today's open
$437.33
Day's range
$428.71 - $441.29
52 week range
$328.57 - $603.88
show more
CEO
DAVID J. ROSA
Employees
17021
Headquarters
Sunnyvale, CA
Exchange
Nasdaq Global Select
Shares outstanding
346643718
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
ISRG EPS Climbs 25% to $3: Is Innovation Driving Profitable Growth?
Intuitive Surgical's adjusted EPS surged 25% as robotic platform adoption and AI innovation fueled growth, despite rising R&D costs and a litigation settlement.
Zacks Investment Research • a day ago

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks Investment Research • 21 hours ago

Where Will Intuitive Surgical Be in 10 Years? Hint: Its da Vinci 5 Installed Base Just Topped 2,000
The da Vinci 5 is experiencing rapid adoption. Fewer than 8% of eligible procedures are robotic, leaving a long runway for growth.
The Motley Fool • Nov 15, 2026

ISRG Agrees to $450M Settlement: What Does It Mean for Investors?
Intuitive Surgical's $450 million settlement weighs on Q3 earnings, but strong revenues and procedure growth highlight underlying momentum.
Zacks Investment Research • Nov 12, 2026

Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Zacks Investment Research • Nov 12, 2026

Intuitive Surgical: Why I Remain Bullish Despite Cutting My Price Target
Intuitive Surgical delivered strong Q3 2026 results with 22% revenue growth, 84% recurring revenue, and robust system placements, reinforcing my 'Buy' rating. ISRG's updated price target is $553, reflecting a more balanced EV/EBITDA multiple amid competitive and geographic pressures, yet still offering 23% upside. Upcoming 3%-5% instrument revenue-per-procedure headwinds and China price cuts are offset by expanding benign procedure adoption and installed base leverage.
Seeking Alpha • Nov 12, 2026

Is Intuitive Surgical (ISRG) a Solid Growth Stock? 3 Reasons to Think "Yes"
Intuitive Surgical (ISRG) could produce exceptional returns because of its solid growth attributes.
Zacks Investment Research • Nov 11, 2026

Nasdaq-100 Correction: 2 Proven Winners That Can Buck Historic Volatility
Wall Street volatility is picking up, with the Nasdaq Composite logging its largest-ever single-day point decline and the Nasdaq-100 losing roughly 15% in one month. A healthcare stock with a sustained double-digit growth rate and a wide moat is begging to be bought.
The Motley Fool • Nov 10, 2026

Intuitive Surgical (ISRG) Just Grew Revenue 22%. Why Is the Stock Still Down This Year?
Intuitive Surgical is a giant in its field. It faces growing competition.
The Motley Fool • Nov 9, 2026

ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue?
Intuitive Surgical shares gained 7.8% in six months as robust procedure growth and da Vinci 5 adoption offset litigation costs, competition and valuation concerns.
Zacks Investment Research • Nov 9, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Intuitive Surgical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.